Alessandra Caruso

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities.

Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities.

Journal: Biology

Published: October 10, 2022

Postweaning social isolation and autism-like phenotype: A biochemical and behavioral comparative analysis.

Postweaning social isolation and autism-like phenotype: A biochemical and behavioral comparative analysis.

Journal: Behavioural brain research

Published: November 29, 2021

Risk Factors for Alzheimer's Disease: Focus on Stress.

Risk Factors for Alzheimer's Disease: Focus on Stress.

Journal: Frontiers in pharmacology

Published: May 24, 2019

The positive allosteric modulator at mGlu2 receptors, LY487379, reverses the effects of chronic stress-induced behavioral maladaptation and synaptic dysfunction in the adulthood.

The positive allosteric modulator at mGlu2 receptors, LY487379, reverses the effects of chronic stress-induced behavioral maladaptation and synaptic dysfunction in the adulthood.

Journal: Synapse (New York, N.Y.)

Published: February 14, 2019

Stress as risk factor for Alzheimer's disease.

Stress as risk factor for Alzheimer's disease.

Journal: Pharmacological research

Published: February 14, 2018

Morphine Withdrawal Modifies Prion Protein Expression in Rat Hippocampus.

Morphine Withdrawal Modifies Prion Protein Expression in Rat Hippocampus.

Journal: PloS one

Published: June 07, 2016

Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice.

Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice.

Journal: Synapse (New York, N.Y.)

Published: January 25, 2016

Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia.

Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia.

Journal: Scientific reports

Published: June 17, 2015

Antidepressant activity of fingolimod in mice.

Antidepressant activity of fingolimod in mice.

Journal: Pharmacology research & perspectives

Published: August 21, 2014

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease.

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease.

Journal: Drug design, development and therapy

Published: November 21, 2013

Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.

Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.

Journal: Neuropharmacology

Published: October 21, 2013

L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.

L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 06, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026